modafinil has been researched along with Body Weight in 9 studies
Modafinil: A benzhydryl acetamide compound, central nervous system stimulant, and CYP3A4 inducing agent that is used in the treatment of NARCOLEPSY and SLEEP WAKE DISORDERS.
modafinil : A racemate comprising equimolar amounts of armodafinil and (S)-modafinil. A central nervous system stimulant, it is used for the treatment of sleeping disorders such as narcolepsy, obstructive sleep apnoea, and shift-work sleep disorder. The optical enantiomers of modafinil have similar pharmacological actions in animals.
2-[(diphenylmethyl)sulfinyl]acetamide : A sulfoxide that is dimethylsulfoxide in which two hydrogens attached to one of the methyl groups are replaced by phenyl groups, while one hydrogen attached to the other methyl group is replaced by a carbamoyl (aminocarbonyl) group.
Body Weight: The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Results of this pilot trial do not support routine use of modafinil to counteract increased weight and metabolic diseases in patients taking clozapine." | 9.15 | Effects of modafinil on weight, glucose and lipid metabolism in clozapine-treated patients with schizophrenia. ( Borba, CP; Cather, C; Copeland, PM; Fan, X; Freudenreich, O; Goff, DC; Henderson, DC; Macklin, E; Wang, X, 2011) |
| "After an initial patient with cerebral palsy had an apparent dramatic reduction in spasticity when placed on modafinil, a pilot study was undertaken in 10 pediatric patients to confirm or refute the benefit of modafinil in cerebral palsy." | 7.71 | Use of modafinil in spastic cerebral palsy. ( Hurst, DL; Lajara-Nanson, W, 2002) |
| "Modafinil plays a role in vasorelaxation and blocking KCa3." | 5.43 | Modafinil improves monocrotaline-induced pulmonary hypertension rat model. ( Cho, MS; Hong, YM; Kim, KC; Lee, H; Suh, SH, 2016) |
| "Results of this pilot trial do not support routine use of modafinil to counteract increased weight and metabolic diseases in patients taking clozapine." | 5.15 | Effects of modafinil on weight, glucose and lipid metabolism in clozapine-treated patients with schizophrenia. ( Borba, CP; Cather, C; Copeland, PM; Fan, X; Freudenreich, O; Goff, DC; Henderson, DC; Macklin, E; Wang, X, 2011) |
| "After an initial patient with cerebral palsy had an apparent dramatic reduction in spasticity when placed on modafinil, a pilot study was undertaken in 10 pediatric patients to confirm or refute the benefit of modafinil in cerebral palsy." | 3.71 | Use of modafinil in spastic cerebral palsy. ( Hurst, DL; Lajara-Nanson, W, 2002) |
| "Modafinil was generally well tolerated." | 2.72 | Modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, fixed-dose study followed by abrupt discontinuation. ( Biederman, J; Earl, CQ; Greenhill, LL; Jiang, JG; Lopez, FA; Sedillo, A; Swanson, JM, 2006) |
| "This randomized, double-blind, placebo-controlled study assessed the efficacy and tolerability of several modafinil dosing regimens in children with attention-deficit/hyperactivity disorder (ADHD) to determine whether modafinil can be given once daily in pediatric ADHD." | 2.72 | A comparison of once-daily and divided doses of modafinil in children with attention-deficit/hyperactivity disorder: a randomized, double-blind, and placebo-controlled study. ( Biederman, J; Boellner, SW; Earl, CQ; Lopez, FA; Swanson, JM; Wigal, SB, 2006) |
| "Modafinil plays a role in vasorelaxation and blocking KCa3." | 1.43 | Modafinil improves monocrotaline-induced pulmonary hypertension rat model. ( Cho, MS; Hong, YM; Kim, KC; Lee, H; Suh, SH, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Murphy, HM | 1 |
| Ekstrand, D | 1 |
| Tarchick, M | 1 |
| Wideman, CH | 1 |
| Lee, H | 1 |
| Kim, KC | 1 |
| Cho, MS | 1 |
| Suh, SH | 1 |
| Hong, YM | 1 |
| Pallier, PN | 1 |
| Morton, AJ | 1 |
| Nguyen, TL | 1 |
| Tian, YH | 1 |
| You, IJ | 1 |
| Lee, SY | 1 |
| Jang, CG | 1 |
| Henderson, DC | 1 |
| Freudenreich, O | 1 |
| Borba, CP | 1 |
| Wang, X | 1 |
| Copeland, PM | 1 |
| Macklin, E | 1 |
| Fan, X | 1 |
| Cather, C | 1 |
| Goff, DC | 1 |
| Ray, K | 1 |
| Chatterjee, A | 1 |
| Panjwani, U | 1 |
| Kumar, S | 1 |
| Sahu, S | 1 |
| Ghosh, S | 1 |
| Thakur, L | 1 |
| Anand, JP | 1 |
| Swanson, JM | 2 |
| Greenhill, LL | 1 |
| Lopez, FA | 2 |
| Sedillo, A | 1 |
| Earl, CQ | 2 |
| Jiang, JG | 1 |
| Biederman, J | 2 |
| Wigal, SB | 1 |
| Boellner, SW | 1 |
| Hurst, DL | 1 |
| Lajara-Nanson, W | 1 |
3 trials available for modafinil and Body Weight
| Article | Year |
|---|---|
Effects of modafinil on weight, glucose and lipid metabolism in clozapine-treated patients with schizophrenia.
Topics: Adult; Analysis of Variance; Benzhydryl Compounds; Blood Glucose; Blood Pressure; Body Weight; Cloza | 2011 |
Modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, fixed-dose study followed by abrupt discontinuation.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Benzhydryl Compounds; Body Weight; Centra | 2006 |
A comparison of once-daily and divided doses of modafinil in children with attention-deficit/hyperactivity disorder: a randomized, double-blind, and placebo-controlled study.
Topics: Adolescent; Age Factors; Attention Deficit Disorder with Hyperactivity; Benzhydryl Compounds; Body W | 2006 |
6 other studies available for modafinil and Body Weight
| Article | Year |
|---|---|
Modafinil as a cognitive enhancer of spatial working memory in rats.
Topics: Animals; Benzhydryl Compounds; Body Weight; Eating; Male; Maze Learning; Memory, Short-Term; Modafin | 2015 |
Modafinil improves monocrotaline-induced pulmonary hypertension rat model.
Topics: Animals; Benzhydryl Compounds; Body Weight; Cyclic AMP; Disease Models, Animal; Endothelin-1; Gene E | 2016 |
Management of sleep/wake cycles improves cognitive function in a transgenic mouse model of Huntington's disease.
Topics: Affect; Alprazolam; Animals; Benzhydryl Compounds; Body Weight; Central Nervous System Stimulants; C | 2009 |
Modafinil-induced conditioned place preference via dopaminergic system in mice.
Topics: Animals; Autoradiography; Benzhydryl Compounds; Body Weight; Brain; Central Nervous System Stimulant | 2011 |
Modafinil improves event related potentials P300 and contingent negative variation after 24 h sleep deprivation.
Topics: Actigraphy; Adult; Benzhydryl Compounds; Body Weight; Central Nervous System Stimulants; Cognition; | 2012 |
Use of modafinil in spastic cerebral palsy.
Topics: Adolescent; Benzhydryl Compounds; Body Weight; Central Nervous System Stimulants; Cerebral Palsy; Ch | 2002 |